Meridian Bioscience Inc (VIVO.OQ)
23 Apr 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|69||2017||Executive Chairman of the Board|
|49||2017||Chief Executive Officer, Director|
|54||2009||Chief Financial Officer, Executive Vice President, Secretary|
|63||2011||President and Managing Director of Meridian Bioscience Europe|
|58||2016||Executive Vice President and President - Global Operations|
- BRIEF-FDA Continues To Recommend Magellan Lead Tests Not Be Used With Samples Taken From Vein
- BRIEF-Meridian Bioscience Reports Q1 GAAP EPS Of $0.15
- BRIEF-FDA Issues Warning Letter To Becton Dickinson & Co
- BRIEF-Meridian Bioscience Files For Mixed Shelf Of Up To $100 Million
- CORRECTED-UPDATE 2-FDA warns Meridian of violations for lead-testing devices